Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy?

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society - 1 Sept 2000

Mashima Y, Kigasawa K, Wakakura M, Oguchi Y

Abstract excerpt

OBJECTIVES: The authors investigated the effectiveness of idebenone combined with vitamin B2 and vitamin C in the treatment of patients with Leber hereditary optic neuropathy (LHON) in an early stage as compared with untreated patients with LHON. These agents may stimulate the formation of ATP. MATERIALS AND METHODS: For this retrospective study, the authors selected 28 outpatients with LHON from the Keio...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ascorbic Acid
Share to Benzoquinones

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Optic Atrophies, Hereditary

Share to Recovery of Function

Share to Riboflavin

Share to Ubiquinone

Share to Vision Disorders

Share to Visual Acuity

Source

Identifiers

PMID: 11001192
DOI: 10.1097/00041327-200020030-00006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy?PMID 11001192Read ↗

Clinical Characteristics of m.11778G>A Leber Hereditary Optic Neuropathy with Favorable Outcomes.Semantic proximity Read ↗

Leber's hereditary optic neuropathy: course of disease in consideration of idebenone treatment and type of mutation.Semantic proximity Read ↗

Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial.Semantic proximity Read ↗

Clinical trials in Leber hereditary optic neuropathy: outcomes and opportunities.Semantic proximity Read ↗

Leber’s hereditary optic neuropathy: Update on current diagnosis and treatmentSemantic proximity Read ↗

Systematic review of Leber's hereditary optic neuropathy - Clinical diagnosis, genetics overview and current concepts of treatment.Semantic proximity Read ↗

Developments in the Treatment of Leber Hereditary Optic Neuropathy.Semantic proximity Read ↗

Further advances in the diagnosis and treatment of Leber's Hereditary Optic Neuropathy - a review.Semantic proximity Read ↗

Outcomes of Idebenone Therapy for Leber Hereditary Optic Neuropathy in a cohort of patients from WalesSemantic proximity Read ↗

[Medical treatments in Leber's hereditary optic neuropathy].Semantic proximity Read ↗

A Typical Case Presentation with Spontaneous Visual Recovery in Patient Diagnosed with Leber Hereditary Optic Neuropathy due to Rare Point Mutation in MT-ND4 Gene (m.11253T>C) and Literature Review.Semantic proximity Read ↗

[A clinical study of Leber hereditary optic neuropathy].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.